AZ Turnhout, Campus Sint-Elisabeth

Turnhout 2300

0 studies enrolling now · 3 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Diffuse Large B-cell Lymphoma, Gastric Cancer Third Line, Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma — Stopped early
• A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
• Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) — Completed